baber/WOPTO huggingface dataset:
Patent NZ-567803-A (NZ)
Title: Method for manufacture of sanitised organic sludge
Inventor: AANEROD KJELL
IPC: C05F17/40
Filed: 2006-10-31
Abstract: Disclosed is a method for manufacture of sanitised organic sludge, characterised in that the method encompasses the following steps: mechanical mixing of shredded newspaper with a polyacrylamide or another biological degradable super absorbent and dewatered organic sludge, wherein said super absorbent is in the order of 2 % by weight, said dewatered organic sludge has a dry matter content of 20-25 % by weight, and the amount of shredded newspaper in relation to the dewatered organic sludge is 5-10 % by weight, lead the sludge mixture containing super absorbent and shredded newspaper to a sanitising container, continuously supply air to the sludge mixture until the desired temperature of 58 degrees Celsius to 60 degrees Celsius has been reached.
Patent NZ-571273-A (NZ)
Title: Receiving hot compressed gas in pressure vessels with two layers of dessicant and regenerating the dessicant using the heat from the gas
Inventor: HUBERLAND FILIP GUSTAFF M
IPC: B01D53/04
Filed: 2007-03-05
Abstract: Disclosed is a device for drying a hot compressed gas. The device comprises of a compressed gas supply (2) and two pressure vessels (33, 34). The vessels are provided with an input (37, 38) and an output (39, 40) and a take-up point (32) f or users of compressed dried gas. At least two layers of desiccant (35 and 36) are provided in each pressure vessel, a first layer (35) made of a waterproof desiccant and a second layer (36) which is not necessarily made of a waterproof desiccant. The pressure vessels are provided with a second input (41, 42) for the supply of compressed gas to regenerate desiccant from the first layer.
Patent NZ-572661-A (NZ)
Title: Optically controlled silicon carbide and related wide-bandgap transistors and thyristors
Inventor: MAZZOLA MICHAEL S
IPC: H02M7/00
Filed: 2007-06-19
Abstract: A semiconductor device is disclosed. The device comprises a substrate. An optically active, semi-insulating silicon carbide (SiC) layer is applied over the substrate. The SiC layer has a boron-related D-center defects formed in it. The device further comprises an electromagnetic radiation source. The electromagnetic radiation source is configured to direct electromagnetic radiation onto the surface of the SiC layer. The electromagnetic radiation source produces electromagnetic radiation having at least a first wavelength that stimulates photoconductivity in the SiC layer and a second wavelength that quenches photo conductivity in the SiC layer.
Patent NZ-576290-A (NZ)
Title: Light wood-based materials
Inventor: SCHMIDT MICHAEL
IPC: B27N3/00
Filed: 2007-10-18
Abstract: Disclosed is a light wood-containing material having an average density in the range from 200 to 600 kg/m3, comprising, based in each case on the wood-containing material: A) from 30 to 95% by weight of wood particles; B) from 1 to 25% by weight of a filler having a bulk density in the range from 10 to 150 kg/m3, selected from the group consisting of foamable plastic particles and already foamed plastic particles; C) from 0.1 to 50% by weight of a binder and, if appropriate, D) additives, the following relationship being true for the d' values according to Rosin-Rammler-Sperling-Bennet of the wood particles A) and of the particles of the filler B): d' of the particles A) is less than or equal to 2.5 x d' of the particles B).
Patent NZ-581726-A (NZ)
Title: Respriatory mask with flexible forehead support
Inventor: BRAMBILLA ENRICO
IPC: A61M16/06
Filed: 2008-06-19
Abstract: A respiratory mask includes a mask frame and a forehead support provided to the mask frame. The forehead support includes a base extending from the frame. The base includes a flexible portion along at least a portion of its length including a material and/or physical characteristic that allows the base to flex from an original, unloaded position.
Patent NZ-581836-A (NZ)
Title: A drug delivery system for the prevention of cerebral vasospasm
Inventor: LEUTHNER BRIAN
IPC: A61K31/553
Filed: 2008-06-11
Abstract: The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm.
Patent NZ-581854-A (NZ)
Title: A bracket system for reinforcing of concrete block walls
Inventor: RAFFERTY CHRISTOPHER CHARLES
IPC: E04B2/20
Filed: 2008-07-18
Abstract: Disclosed is a bracket (10) for locating a longitudinal reinforcement bar (12) within a block wall, the bracket (10) comprising: a capture zone (34), including at least one locating flap (33), to capture a longitudinal reinforcement bar placed longitudinally through a void of a block wall; and a locator for locating said capture zone (34) in a predetermined position with the void of the block wall; wherein the locator includes a plurality of locating fingers (25) which engage an inner wall of a void of a block wall. Also disclosed is a block wall system incorporating the brackets and a method of wall construction.
Patent NZ-582930-A (NZ)
Title: Tissue kallikrein for the treatment of diseases associated with amyloid protein
Inventor: WILLIAMS MARK
IPC: A61K31/00
Filed: 2008-07-18
Abstract: Disclosed are methods of treating Alzheimer's disease or symptoms thereof, and amnesic mild cognitive impairment or symptoms thereof. Methods of the invention include administering a therapeutically effective amount of tissue kallikrein, variants or active fragments thereof. The invention further relates to uses of tissue kallikrein or a variant or active fragment thereof for the digesting or cleaving amyloid and the treatment of conditions benefiting from the digestion or cleavage of amyloid. The invention further relates to pharmaceutical compositions comprising a therapeutically effective amount of tissue kallikrein, variants or active fragments thereof formulated for oral or intranasal administration.
Patent NZ-584986-A (NZ)
Title: Work implement such as mower deck with wings lifted to slacken and disengage transmission
Inventor: MCEWEN JAMES IAIN
IPC: A01D34/00
Filed: 2011-04-29
Abstract: A work implement, including a frame, a drive axle, a central work portion substantially in line with and coupled to the drive axle, at least one additional work portion pivotally mounted to the frame, at least one actuator configured to pivot the at least one additional work portion with respect to the frame, characterised in that each of the at least one work portions is operatively coupled to the drive axle by a drive belt such that pivoting of the at least one additional work portion by the actuator causes the drive belt to slacken thereby disengaging the at least one work portion.
Patent NZ-585862-A (NZ)
Title: Hollow wall construction using panel joining profiles that are connected together by spacers
Inventor: EMBLIN ALAN GAYNE
IPC: E04B2/28
Filed: 2008-12-02
Abstract: A method of constructing a wall is disclosed. The method includes providing first and second spaced apart wall portions (1300, 1400, 1500, 1503) for receiving a filling material. Each wall portion includes at least one track (1210,) on a support (1200) and at least two support members (1221, 1222, 1223, 1224, 1225, 1226). Each support member is aligned with the track and extends from the support. A wall panel is supported by the track(s), support members and at least one joining member (1330, 1430, 1530) coupled to the wall panel and the support members. Spacers (1515) are also coupled to and extend between the wall portions.
Patent NZ-595863-A (NZ)
Title: Antibodies to egfl7 and methods for their use
Inventor: YE WEILAN
IPC: A61P27/02
Filed: 2007-03-16
Abstract: 595863 Disclosed is an anti-EGFL7 antibody (muMab 4F11.1.8) produced by the ATCC hybridoma cell line PTA-7343, an antibody that specifically binds to human EGFL7 at the epitope CCP or antibodies which competes for binding with EGFL7 thereof.
Patent NZ-597147-A (NZ)
Title: Predicting warp potential of a wood product by making a 3D image of the product to create a profile with geometric data, then subtracting geometric components from the data
Inventor: TOLAND MITCHELL R
IPC: G01N23/00
Filed: 2010-06-29
Abstract: Disclosed is a method for predicting warp of a wood product produced from a log. The method includes performing a three dimensional scan of the log to obtain geometric data and, using the geometric data, constructing a log profile. The geometric data is partitioned into geometric components, one or more of which are removed from the geometric data to create one or more residual grid profiles. From the grid profiles, geometric statistics are derived and entered into a model for predicting warp of the wood product. The geometric statistics compose orientation dependent statistics.
Patent NZ-598044-A (NZ)
Title: Dynamic voltage restoration system and method
Inventor: PAMULAPARTHY BALAKRISHNA
IPC: G05F5/04
Filed: 2012-02-07
Abstract: 598044 Disclosed is a voltage restoration system for automatically correcting voltage sag in a power distribution network. The system includes a voltage fault detection system (22) configured to acquire a reference voltage signal (60) from a power line. The detection system (22) is also configured to determine if a voltage sag condition is present in the power line and, if so, determine a correction voltage for correcting the voltage sag condition. The detection system uses the reference voltage (60) to produce the correction voltage (64) based on the difference between the reference voltage (60) and a target voltage. The detection system (22) generates the correction voltage (64) by applying the reference voltage (60) to a primary winding of a shunt transformer (54) and controlling a secondary winding of the shunt transformer (54) to induce the correction voltage (64) based on the applied reference voltage (60). The correction voltage (64) is applied when the duration of the voltage sag condition is determined to have exceeded a predetermined limit.
Patent NZ-600116-A (NZ)
Title: Method and facility for drying slurry-like materials, in particular sludge from wastewater treatment plants
Inventor: PARDO PIERRE EMMANUEL
IPC: F26B23/00
Filed: 2010-11-19
Abstract: 600116 Disclosed is a method for drying slurry-like materials, in particular sludge from wastewater treatment plants, including two drying stages, namely: a first indirect drying stage (2), supplied with hot fluid, which receives sludge having an entry dryness Se, and outputs sludge having an intermediate dryness Si and water steam, which is channelled towards a condenser (8) in which a heating fluid, in particular water, is reheated and, in turn, heats a heating gas for a second drying stage (6); and a step (5) of forming strings of sludge at the exit from the first stage; the second stage (6) of drying the strings of sludge using gas at least partially heated by the heat extracted from the condenser, said second stage outputting a slurry having a final dryness Sf; the intermediate dryness Si is controlled according to the measured entry dryness Se and the desired exit dryness Sf, for minimum consumption of the total energy used for drying, the flow rate, pressure and/or temperature of the hot fluid (3) supplying the first drying stage (2) being adjusted accordingly.
Patent NZ-602892-A (NZ)
Title: Antibodies that bind human cd27 and uses thereof
Inventor: THOMAS LAWRENCE J
IPC: A61K39/00
Filed: 2011-04-13
Abstract: Disclosed is an isolated monoclonal antibody which binds to human CD27, wherein the antibody comprises: a heavy chain variable region CDR1 comprising SEQ ID NO: 38, a heavy chain variable region CDR2 comprising SEQ ID NO: 39, a heavy chain variable region CDR3 comprising SEQ ID NO: 40, a light chain variable region CDR1 comprising SEQ ID NO: 44, a light chain variable region CDR2 comprising SEQ ID NO: 45, and a light chain variable region CDR3 comprising SEQ ID NO: 46; a heavy chain variable region and a light chain variable region comprising an amino acid sequence at least 85% identical to the amino acid sequences set forth in SEQ ID NOs: 37 and 43, respectively; or a heavy chain variable region and a light chain variable region encoded by nucleic acid sequences at least 90% identical to the nucleic acid sequences set forth in SEQ ID NOs: 35 and 41, respectively, wherein the sequences are as defined in the complete specification. Also disclosed is the use of the antibody in the manufacture of a medicament for treating cancer.
Patent NZ-609420-A (NZ)
Title: Fulvestrant compositions and methods of use
Inventor: SWART HENK
IPC: A61K47/40
Filed: 2011-09-16
Abstract: Disclosed are inclusion complexes comprising fulvestrant (7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl)nonyl]estra-1,3, 5-(10)-triene-3,17-beta-diol) represented by formula (I) and a cyclodextrin and uses of the complexes in the treatment of diseases necessitating antiestrogen therapy or estrogen receptor downregulation such as particular cancers and systemic lupus erythematosus. Also provided are methods of producing the inclusion complexes, methods of treatment using the complexes, formulations comprising the complexes and kits and unit dosages comprising the complexes.
Patent NZ-617436-A (NZ)
Title: Height control valve assembly for axle/suspension systems
Inventor: YAGIELA MICHAEL W
IPC: B60G11/26
Filed: 2012-06-14
Abstract: A height control valve assembly for an axle/suspension system of a vehicle includes a height control valve in fluid communication with a compressed air source, with at least one air spring of the vehicle, and with atmosphere. The height control valve is attached to the frame of the vehicle and includes a flow control means for regulating fluid flow through the valve. A control arm is operatively attached to the flow control means, whereby movement of the control arm regulates fluid flow through the height control valve. The height control valve assembly further includes a link 150 having a first end and a second end. The first end of the link 150 is formed with a loop 157. A disk is formed with an opening being disposed into the loop of the link 150. The first end of the link 150 is operatively attached to the second end of the control arm via a fastener disposed through the disk opening and through an opening formed in the second end of the control arm. The disk is attached to the second end of the control arm opposite the first end of the control arm operatively attached to the height control valve. The second end of the link 150 comprises a first bend of about 90 degrees and a second bend of about 90 degrees. At least one of the first or second bends is disposed through an opening formed in a beam of the suspension system to attach the second end of the link 150 to the beam. The second end of the link 150 is free of fasteners and any intervening structure.
Patent NZ-618999-A (NZ)
Title: Heat absorbing door for a refrigerated merchandiser
Inventor: REICHERT CRAIG STEVEN
IPC: A47F3/04
Filed: 2012-07-02
Abstract: A door for a refrigerated merchandiser including a case that defines a product display area. The door includes a frame and a first glass pane coupled to the frame. The first glass pane has heat-absorbing glass and is configured to be positioned adjacent an ambient environment surrounding the refrigerated merchandiser to absorb radiation from the ambient environment. The door also includes a second glass pane coupled to the frame and configured to be positioned adjacent the product display area. The second glass pane includes a conductive coating. The door further includes a third glass pane positioned between and spaced from the first glass pane and the second glass pane, and has a low emissivity coating.
Patent NZ-624786-A (NZ)
Title: Stable sulfoximine-insecticide compositions
Inventor: BOUCHER RAYMOND E JR
IPC: C07D409/04
Filed: 2009-12-22
Abstract: The disclosure relates to a composition comprising an insecticide compound (as shown herein) and an organic acid or a salt thereof, wherein the ratio between the compound according to formula (I) and the organic acid is about 300:1 to about 10:1. The organic acid may be selected from the group consisting of citric acid, phthalic acid, malic acid, tartaric acid, maleic acid, malonic acid, lactic acid and succinic acid. The compound contains a sulfoximine and a 6-haloalkylpyridin-3-yl. The sulfoximine is optionally also bound to a carbon to form a 5 membered thiolane (tetrahydrothiophene). The composition comprising this compound and the organic acid or salt thereof exhibits increased stability and may optionally include another insecticide. Methods of controlling insects using the composition are also disclosed.
Patent NZ-701122-A (NZ)
Title: Agents for treating disorders involving modulation of ryanodine receptors
Inventor: PEGLION JEAN-LOUIS
IPC: C07D285/36
Filed: 2013-04-17
Abstract: The present invention relates to 1,4-benzothiazepine derivatives of formula I and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.
Patent NZ-709884-A (NZ)
Title: Apparatus and method for powering and networking a rail of a firearm
Inventor: COMPTON DAVID WALTER
IPC: H04B5/00
Filed: 2012-02-14
Abstract: Disclosed is a weapon comprising an upper receiver; a lower receiver; a powered accessory mounted to a rail of the upper receiver; and an apparatus for networking a microcontroller of the powered accessory to a microcontroller of the rail of the upper receiver and a master CPU of the weapon. Data is exclusively provided to the powered accessory from one of a plurality of slots located within the rail. The powered accessory is configured to determine when one of the plurality of slots of the powered accessory is adjacent to the one of the plurality of slots of the rail.
Patent NZ-711569-A (NZ)
Title: Single high dose of mva induces a protective immune response in neonates and infants
Inventor: CHEMINAY CÉDRIC
IPC: A61K39/165
Filed: 2014-03-14
Abstract: The invention relates to compositions and methods for inducing a protective immune response against a poxvirus in a human neonate or infant of less than 6 months of age. The invention encompasses administering a single high dose of at least 10^8 TCID50 of an MVA to a human neonate or infant of less than 6 months of age, wherein the administration induces protective T- and B-cell responses against a poxvirus in the human neonate or infant.
Patent NZ-725828-A (NZ)
Title: Pharmaceutical solution comprising dopamine for use in treating parkinson’s disease
Inventor: DEVOS DAVID
IPC: A61K31/137
Filed: 2015-05-12
Abstract: The present invention is directed to a pharmaceutical solution comprising at least dopamine for use in treating Parkinson’s disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration in order to reduce dopamine oxidation. The present invention also demonstrates neuroprotective effects. In mouse model experiments, animals treated with anaerobic dopamine infusion had a significant increase in Th-expressing neurons compared to MPTP-treated mice.
Patent NZ-728043-A (NZ)
Title: Method and arrangement for performing teat related operations in a rotary milking system and rotary milking system
Inventor: NILSSON MATS
IPC: A01J7/04
Filed: 2015-08-20
Abstract: An arrangement is provided for performing teat related operations in a rotary milking system (11) comprising a rotating platform (13), a plurality of milking stalls (13a) arranged thereon, each of which being provided with teat cups (15) and provided for housing a milking animal (17) during milking thereof; and at least one robot (19) having a capacity for performing operations with respect to teats of milking animals present in milking stalls of the rotary milking system within a first zone (C1), through which the rotating platform passes once for each revolution the rotary platform rotates, during an operation condition when the capacity required for performing the operations with respect to the teats of the milking animals to be milked in the rotary milking system is higher than the capacity of said at least one robot. A capacity required for performing the operations with respect to the teats of the milking animals to be milked in the rotary milking system is estimated. A semi-automated teat related operation procedure is planned based on the capacity of said at least one robot and the estimated required capacity, according to which procedure a first fraction of the operations with respect to the teats of the milking animals should be performed, in the first zone, by said at least one robot automatically, and a second fraction of the operations with respect to the teats of the milking animals should be performed manually in a second zone (C2) located adjacent to said first zone (C1). Finally, the operations with respect to the teats of the milking animals are performed according to the planned semi-automated teat related operation procedure.
Patent NZ-732402-A (NZ)
Title: Nitrification inhibitor compositions and methods for preparing the same
Inventor: DAVE HITESHKUMAR
IPC: C05G3/90
Filed: 2015-12-23
Abstract: The present disclosure relates to enhanced nitrification inhibitor compositions, methods for making the same, and their use in agricultural applications. The disclosure relates to the prevention of crystallisation of nitrification inhibitors in agricultural formulations by the identification and inclusion of materials in agricultural formulations that prevent the crystallisation of nitrification inhibitors.
Patent NZ-738063-A (NZ)
Title: Stable povidone-iodine compositions
Inventor: WEISER MICHAEL
IPC: A61K33/18
Filed: 2012-09-14
Abstract: Disclosed herein are povidone-iodine (PVP-I) containing compositions, as well as methods of making such compositions, which provide reliable stability for PVP-I preparations, including preparations comprising PVP-I and one or more additional components. The compositions may optionally comprise a non-steroidal anti-inflammatory agent such as amfenac, ketorlac or a steroid such as dexamethasone. The compositions are suitable for topical application and can be used in treating an eye disorder or microorganism infection of at least one tissue of the eye.